A Colorectal Cancer Moonshot

Clinical Gastroenterology and Hepatology

Volumn 15, Issue 6, 2017, Pages 910-912

  Kahi, Charles J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CANCER THERAPY; COLONOSCOPY; COLORECTAL CANCER; EARLY CANCER DIAGNOSIS; EDITORIAL; HEALTH CARE ACCESS; HEALTH PROMOTION; HUMAN; LIFESTYLE; PHYSICAL ACTIVITY; RISK REDUCTION; SECONDARY PREVENTION; SMOKING; AGING; COLON TUMOR; COLORECTAL TUMOR; INCIDENCE; NEOPLASM;

AGING; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; HUMANS; INCIDENCE; NEOPLASMS;

EID: 85013672166     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2017.01.005     Document Type: Editorial

References (16)

1. 1 https://www.whitehouse.gov/sites/default/files/docs/final_cancer_moonshot_task_force_report_1.pdf. Accessed December 28, 2016.
2. 2 http://nccrt.org/tools/80-percent-by-2018/. Accessed December 28, 2016.
3. 3 Wilson, J.M.G., Jungner, G., Principles and practices of screening for disease. 1968, World Health Organization, Geneva, Switzerland Public Health Papers No. 34. Available at: http://whqlibdoc.who.int/php/WHO_PHP_34.pdf. Accessed December 28, 2016.
4. 4 Fletcher, R., Fletcher, S., Wagner, E., Clinical epidemiology the essentials. 3rd ed., 1996, Lippincott Williams and Wilkins, Philadelphia.
5. 5 Gilbertsen, V.A., Knatterud, G.L., Lober, P.H., et al. Invasive carcinoma of the large intestine: a preventable disease?. Surgery 57 (1965), 363–365.
6. 6 Vogelstein, B., Fearon, E.R., Hamilton, S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988), 525–532.
7. 7 Kubisch, C.H., Crispin, A., Mansmann, U., et al. Screening for colorectal cancer is associated with lower disease stage: a population-based study. Clin Gastroenterol Hepatol 14 (2016), 1612–1618.
8. 8 Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA Cancer J Clin 66 (2016), 7–30.
9. 9 Welch, H.G., Robertson, D.J., Colorectal cancer on the decline–why screening can't explain it all. N Engl J Med 374 (2016), 1605–1607.
10. 10 Lee, S.J., Boscardin, W.J., Stijacic-Cenzer, I., et al. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ, 346, 2013, e8441.
11. 11 Tang, V., Boscardin, W.J., Stijacic-Cenzer, I., et al. Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials. BMJ, 350, 2015, h1662.
12. 12 GLOBOCAN 2012 (IARC). Section of Cancer Surveillance (12/12/2016). Available at: www.globocan.iarc.fr. Accessed December 28, 2016.
13. 13 Global Burden of Disease Cancer C, Fitzmaurice, C., Dicker, D., et al. The global burden of cancer 2013. JAMA Oncol 1 (2015), 505–527.
14. 14 Murphy, C.C., Sandler, R.S., Sanoff, H.K., et al. Decrease in incidence of colorectal cancer among individuals 50 years or older after recommendations for population-based screening. Clin Gastroenterol Hepatol 15 (2017), 903–909.
15. 15 Tsoi, K.K.F., Hirai, H.W., Chan, F.C.H., et al. Predicted increases in incidence of colorectal cancer in developed and developing regions, in association with Ageing populations. Clin Gastroenterol Hepatol 15 (2017), 892–900.
16. 16 Brenner, H., Schrotz-King, P., Holleczek, B., et al. Declining bowel cancer incidence and mortality in Germany. Deutsches Arzteblatt International 113 (2016), 101–106.